Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obsessive-compulsive disorder. Characteristic features, pharmacologic management.

D A Casey1

  • 1Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine.

Postgraduate Medicine
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geriatric psychiatry: evolution of an inpatient unit.

Administration and policy in mental health·2000
Same author

Electroconvulsive therapy in the very old.

General hospital psychiatry·1996
Same author

Delirium. Quick recognition, careful evaluation, and appropriate treatment.

Postgraduate medicine·1996
Same author

Adapting cognitive behavioral therapy for the frail elderly.

International psychogeriatrics·1995
Same author

Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman.

Southern medical journal·1994
Same author

Depression in the elderly.

Southern medical journal·1994
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
Same journal

The prevalence of functional iron deficiency and its impact on mortality in patients receiving hemodialysis.

Postgraduate medicine·2026
See all related articles

Obsessive-compulsive disorder (OCD) is a common condition. Research is uncovering its biological basis, with medications like fluoxetine and clomipramine offering treatment hope.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Obsessive-compulsive disorder (OCD) is recognized as a prevalent and complex mental health condition.
  • Understanding the biological underpinnings of OCD is crucial for developing effective treatments.

Purpose of the Study:

  • To explore the current understanding of obsessive-compulsive disorder.
  • To highlight advancements in research into the biological factors contributing to OCD.
  • To review the therapeutic potential of specific pharmacological interventions.

Main Methods:

  • Literature review of recent research on obsessive-compulsive disorder.
  • Analysis of studies investigating the neurobiology of OCD.
  • Examination of clinical trial data for relevant medications.

Related Experiment Videos

Main Results:

  • OCD is more common than previously thought.
  • Emerging research is identifying key biological mechanisms involved in OCD.
  • Pharmacological treatments show promise in alleviating OCD symptoms.

Conclusions:

  • Continued research into the biological basis of OCD is essential.
  • Medications such as fluoxetine hydrochloride and clomipramine hydrochloride represent significant therapeutic advancements.
  • There is growing hope for improved outcomes for individuals with obsessive-compulsive disorder.